Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marvaso

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Clinical Genitourinary Cancer|May 23, 2021
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical ProstatectomySarah Alessi, Roberta Maggioni, Stefano Luzzago, et al.
Physics in Medicine and Biology|May 23, 2018
Multi atlas based segmentation: should we prefer the best atlas group over the group of best atlases?Paolo Zaffino, Delia Ciardo, Patrik Raudaschl, et al.
Critical Reviews in Oncology/Hematology|May 27, 2025
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicityMateusz Bilski, Federico Mastroleo, Łukasz Kuncman, et al.
Radiology|July 29, 2025
Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer DiagnosisCaterina Sattin, Caterina Pizzi, Paul Summers, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Interim <sup>18</sup>FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic reviewMahila Ferrari, Laura Lavinia Travaini, Delia Ciardo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2018
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancerMaddalena Mambretti, Chiara Romanò, Giulia Marvaso, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation TechniqueAndrea Vavassori, Giovanni Mauri, Giovanni Carlo Mazzola, et al.
Medical Oncology (Northwood, London, England)|April 29, 2017
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpressionDaniela Alterio, Giulia Marvaso, Fausto Maffini, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 23, 2020
Effects of MRI image normalization techniques in prostate cancer radiomicsLars J Isaksson, Sara Raimondi, Francesca Botta, et al.
Cancer Biology & Therapy|June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patientsCirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Clinical Genitourinary Cancer|May 23, 2021
Apparent Diffusion Coefficient and Other Preoperative Magnetic Resonance Imaging Features for the Prediction of Positive Surgical Margins in Prostate Cancer Patients Undergoing Radical ProstatectomySarah Alessi, Roberta Maggioni, Stefano Luzzago, et al.
Physics in Medicine and Biology|May 23, 2018
Multi atlas based segmentation: should we prefer the best atlas group over the group of best atlases?Paolo Zaffino, Delia Ciardo, Patrik Raudaschl, et al.
Critical Reviews in Oncology/Hematology|May 27, 2025
Interventional stereotactic radiotherapy (brachytherapy) for unresected brain metastases: Systematic review of outcome and toxicityMateusz Bilski, Federico Mastroleo, Łukasz Kuncman, et al.
Radiology|July 29, 2025
Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer DiagnosisCaterina Sattin, Caterina Pizzi, Paul Summers, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Interim <sup>18</sup>FDG PET/CT during radiochemotherapy in the management of pelvic malignancies: A systematic reviewMahila Ferrari, Laura Lavinia Travaini, Delia Ciardo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2018
A global Unified Dosimetry Index (gUDI) to evaluate simultaneous integrated boost radiotherapy plans in prostate cancerMaddalena Mambretti, Chiara Romanò, Giulia Marvaso, et al.
Current Oncology (Toronto, Ont.)|September 27, 2023
Cyberknife Radiosurgery for Prostate Cancer after Abdominoperineal Resection (CYRANO): The Combined Computer Tomography and Electromagnetic Navigation Guided Transperineal Fiducial Markers Implantation TechniqueAndrea Vavassori, Giovanni Mauri, Giovanni Carlo Mazzola, et al.
Medical Oncology (Northwood, London, England)|April 29, 2017
Role of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpressionDaniela Alterio, Giulia Marvaso, Fausto Maffini, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|February 23, 2020
Effects of MRI image normalization techniques in prostate cancer radiomicsLars J Isaksson, Sara Raimondi, Francesca Botta, et al.
Cancer Biology & Therapy|June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patientsCirino Botta, Vito Barbieri, Domenico Ciliberto, et al.
Pageof 17